美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Evommune

28.85

-0.1800-0.62%

成交量：102.34萬

成交額：2,674.73萬

市值：9.09億

市盈率：-14.48

高：28.99

開：28.00

低：24.12

收：29.03

52周最高：33.20

52周最低：13.89

股本：3,152.41萬

流通股本：940.00萬

量比：0.34

換手率：10.89%

股息：- -

股息率：- -

每股收益(TTM):-1.9930

每股收益(LYR):-45.2873

淨資產收益率：--

總資產收益率：--

市淨率：-4.97

市盈率(LYR):-0.64

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

BUZZ-濕疹療法在中期試驗中表現良好，Evommune業績大漲

Evommune公司：同時評估Evo301的潛在新增適應症，包括潰瘍性結腸炎

Evommune公布Evo301治療中重度特應性皮炎二期a期概念驗證試驗積極頂線數據

Aktis Oncology申請美國IPO，生物技術公司上市反彈

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/EVMN"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":28.85,"timestamp":1770840922416,"preClose":29.03,"halted":0,"volume":1023399,"delay":0,"changeRate":-0.006200482259731303,"floatShares":9400000,"shares":31524093,"eps":-1.993,"marketStatus":"交易中","change":-0.18,"latestTime":"02-11 15:15:22 EST","open":28,"high":28.99,"low":24.12,"amount":26747261.525088,"amplitude":0.167757,"askPrice":28.88,"askSize":72,"bidPrice":28.79,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-1.993,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":29.03,"preHourTrading":{"tag":"盘前","latestPrice":28.03,"preClose":29.03,"latestTime":"09:29 EST","volume":22668,"amount":639745.9299,"timestamp":1770820180452,"change":-1,"changeRate":-0.034447,"amplitude":0.056493},"postHourTrading":{"tag":"盘后","latestPrice":28.36,"preClose":29.03,"latestTime":"19:59 EST","volume":115496,"amount":3300160.185,"timestamp":1770771595296,"change":-0.67,"changeRate":-0.02308,"amplitude":0.078195},"volumeRatio":0.343229},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","floatShares":9400000,"roa":"--","roe":"--","lyrEps":-45.287292,"volumeRatio":0.343229,"shares":31524093,"dividePrice":0,"high":28.99,"amplitude":0.167757,"preClose":29.03,"low":24.12,"week52Low":13.885,"pbRate":"-4.97","psRate":"69.96","week52High":33.2,"institutionHeld":0,"latestPrice":28.85,"committee":-0.756098,"eps":-1.993,"divideRate":0,"volume":1023399,"delay":0,"ttmEps":-1.993,"open":28,"prevYearClose":17.12,"prevWeekClose":17.31,"prevMonthClose":18.1,"prevQuarterClose":17.12,"fiveDayClose":18.94,"twentyDayClose":20.94,"sixtyDayClose":18.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVMN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVMN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1769144400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EVMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EVMN","date":"2026-02-10","current":-13.838435,"percent":0.701493,"low":-11.129537,"twenty":-9.760165,"median":-9.052709,"eighty":-8.555506,"high":-7.430686,"avg":-9.15623,"sd":0.84033,"marketCap":535594340},"quantilePoints":[{"date":"2025-11-07","current":-9.395174,"twenty":-7.823584,"median":-7.430686,"eighty":-7.430686,"marketCap":608469038},{"date":"2025-11-14","current":-8.461694,"twenty":-9.04686,"median":-8.505813,"eighty":-7.430686,"marketCap":548013143},{"date":"2025-11-21","current":-8.689259,"twenty":-9.04686,"median":-8.689259,"eighty":-7.430686,"marketCap":562751147},{"date":"2025-11-28","current":-9.618094,"twenty":-9.051504,"median":-8.707835,"eighty":-8.049291,"marketCap":622906267},{"date":"2025-12-05","current":-10.184684,"twenty":-9.618094,"median":-8.986487,"eighty":-8.483986,"marketCap":659600890},{"date":"2025-12-12","current":-9.657505,"twenty":-9.633858,"median":-9.000419,"eighty":-8.483986,"marketCap":592227156},{"date":"2025-12-19","current":-7.716136,"twenty":-9.618094,"median":-8.986487,"eighty":-8.244704,"marketCap":473176635},{"date":"2025-12-26","current":-9.042428,"twenty":-9.528926,"median":-9.016673,"eighty":-8.355807,"marketCap":554508795},{"date":"2026-01-02","current":-8.800817,"twenty":-9.392482,"median":-9.003431,"eighty":-8.469125,"marketCap":539692472},{"date":"2026-01-09","current":-9.37143,"twenty":-9.380689,"median":-8.972554,"eighty":-8.293747,"marketCap":574684215},{"date":"2026-01-16","current":-10.075701,"twenty":-9.649623,"median":-9.019686,"eighty":-8.354639,"marketCap":617872222},{"date":"2026-01-23","current":-9.710714,"twenty":-9.690151,"median":-9.037572,"eighty":-8.461694,"marketCap":595490116},{"date":"2026-01-30","current":-11.129537,"twenty":-9.775997,"median":-9.042428,"eighty":-8.498847,"marketCap":682496613},{"date":"2026-02-06","current":-8.564346,"twenty":-9.775997,"median":-9.064213,"eighty":-8.549933,"marketCap":525191389},{"date":"2026-02-10","current":-8.733988,"twenty":-9.760165,"median":-9.052709,"eighty":-8.555506,"marketCap":535594340}],"updateTime":1770834107884},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVMN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610062539","title":"BUZZ-濕疹療法在中期試驗中表現良好，Evommune業績大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2610062539","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610062539?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 21:52","pubTimestamp":1770731563,"startTime":"0","endTime":"0","summary":"BUZZ-湿疹疗法在中期试验中表现良好，Evommune业绩大涨2月10日 - ** 药物开发商Evommune EVMN.N 股价盘前大涨102.47%，至33.8美元 ** 该公司称  其试验性疗法 EVO301 在中重度特应性皮炎患者中的测试达到了中期试验的主要目标。** 特应性皮炎或湿疹是一种慢性皮肤病，由于皮肤屏障缺陷和过度活跃的免疫反应，会导致皮肤干燥、发痒、发炎。** 在一项有 70 名患者参加的试验中，与服用安慰剂的患者相比，服用 EVO301 的患者中有 23% 的人皮肤状况清晰或接近清晰，并有明显改善。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL4T3Z61KD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"gpt_icon":0},{"id":"1168920254","title":"Evommune公司：同時評估Evo301的潛在新增適應症，包括潰瘍性結腸炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1168920254","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168920254?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 20:32","pubTimestamp":1770726755,"startTime":"0","endTime":"0","summary":"Evommune公司正在对Evo301的潜在新增适应症展开评估，其中溃疡性结肠炎是重点考察方向之一。这一举措旨在拓宽该药物的应用范围，为更多患者提供治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"gpt_icon":0},{"id":"1100113507","title":"Evommune公布Evo301治療中重度特應性皮炎二期a期概念驗證試驗積極頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1100113507","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100113507?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 20:31","pubTimestamp":1770726682,"startTime":"0","endTime":"0","summary":"生物制药公司Evommune近日宣布，其研发的候选药物Evo301在中重度特应性皮炎患者中开展的二期a期概念验证试验获得积极顶线结果。\n该试验数据表明Evo301在主要疗效终点上表现出显著改善，验证了其治疗潜力。这项突破为后续临床开发奠定了坚实基础，有望为特应性皮炎患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"gpt_icon":0},{"id":"2592118027","title":"Aktis Oncology申請美國IPO，生物技術公司上市反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118027","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118027?lang=zh_tw&edition=fundamental","pubTime":"2025-12-20 06:45","pubTimestamp":1766184351,"startTime":"0","endTime":"0","summary":"Aktis Oncology申请美国IPO，生物技术公司上市反弹路透12月19日 - Aktis Oncology公司周五在美国提交了首次公开募股申请，生物技术行业的股市上市在经历了放缓后出现反弹。Aktis Oncology 公司由生物技术投资者托德-福里于 2020 年 8 月共同创立，目前正在开发治疗多种实体瘤的药物。Aktis Oncology 的主要候选药物 AKY-1189 正在进行早期研究，以治疗某些实体瘤，包括一种晚期膀胱癌、乳腺癌和结直肠癌。Aktis Oncology 公司的前身是 HotKnot Therapeutics 公司，将在纳斯达克上市，股票代码为 \"AKTS\"。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4T3XP1JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","BAC","LU0648001328.SGD","BK4534","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","IE0034235188.USD","LU2129689431.USD","LU1883839398.USD","LU0130102774.USD","LU0321505439.SGD","LU1162221912.USD","LU1074936037.SGD","IE00BKVL7J92.USD","IE00BBT3K403.USD","LU1894683348.USD","BK4553","LU0310800965.SGD","LU0306807586.USD","LU0648000940.SGD","LU2129689514.USD","LU0128525689.USD","LU1035773651.USD","LU1880398554.USD","LU0208291251.USD","LBRX","LU0980610538.SGD","LU0256863902.USD","LU1201861249.SGD","LU0130517989.USD","LU1363072403.SGD","LU1201861165.SGD","LU1668664300.SGD","LU1791807156.HKD","LU1069347547.HKD","EVMN","MPLT","LU0234572021.USD","LU0477156797.USD","IE00B7SZLL34.SGD","MNSH","LU0052756011.USD","LU0320765489.SGD","OWL","LU0256863811.USD","IE0001KFT4U8.USD","LU1804176565.USD","BK4585","LU0130103400.USD","LU0306806265.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EVMN\",params:#limit:6,delay:false,,,undefined,":[]}}